Mpox, a re-emerging zoonotic disease caused by the Mpox virus (MPXV), has become an increasing global health concern due to recurrent outbreaks and the emergence of tecovirimat-resistant strains. The viral P2L protein plays a central role in immune evasion by suppressing host antiviral responses through inhibition of karyopherin-a2 (KPNA2)mediated nuclear import of interferon regulatory factor-3 (IRF3). In this study, a comprehensive comparative and structural analysis of P2L protein variants was conducted using the reference sequence NP_536451.1 to investigate the functional consequences of newly emerged mutations. Multiple sequence alignment identified significant amino acid substitutions across 13 isolates, including recurrent multi-mutation variants (P11S, E25D, A55T, D88N, D112F, and D123G). Computational stability analyses indicated that several substitutions, particularly P11S, E25D, D88N, and D112F, reduce protein stability, while structural modeling revealed notable conformational alterations and changes in transmembrane topology. Molecular docking analyses demonstrated that selected mutant variants, especially P11S, E25D, and D88N, exhibited enhanced binding affinity toward KPNA2 through increased hydrogen-bond and salt-bridge interactions, suggesting a potential gain-of-function mechanism in viral immune evasion. Furthermore, structure-based virtual screening and molecular dynamics simulations identified two promising lead compounds (CID: 73062 and CID: 10494) that formed stable complexes with both wild-type and mutant P2L proteins. Collectively, these findings provide mechanistic insight into mutation-driven modulation of P2L function and establish a computational framework for the development of next-generation antiviral strategies targeting evolving MPXV variants.